Profil
Akihiro Tomoyasu currently works at Kringle Pharma, Inc., as Director from 2016, KinoPharma, Inc., as Director from 2015, PharmaBio Corp., as Outside Director from 2020, HuLA immune, Inc., as Director, GenAhead Bio, Inc., as Outside Director from 2018, and MyMetagenome Co. Ltd., as Director from 2016.
Postes actifs de Akihiro Tomoyasu
| Sociétés | Poste | Début |
|---|---|---|
| KRINGLE PHARMA, INC. | Directeur/Membre du Conseil | 01/12/2016 |
HuLA immune, Inc.
HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for autoimmune diseases | Directeur/Membre du Conseil | 01/02/2019 |
GenAhead Bio, Inc. | Directeur/Membre du Conseil | 01/07/2018 |
MyMetagenome Co. Ltd. | Directeur/Membre du Conseil | 01/02/2016 |
KinoPharma, Inc.
KinoPharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/12/2015 |
PharmaBio Corp.
PharmaBio Corp. BiotechnologyHealth Technology Develops & manufactures regenerative medicines | Directeur/Membre du Conseil | 01/12/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Kringle Pharma, Inc.
Kringle Pharma, Inc. BiotechnologyHealth Technology Researches and develops treatments for regenerative medicine and cancer therapy | Health Technology |
KinoPharma, Inc.
KinoPharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
PharmaBio Corp.
PharmaBio Corp. BiotechnologyHealth Technology Develops & manufactures regenerative medicines | Health Technology |
HuLA immune, Inc.
HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for autoimmune diseases | Health Technology |
GenAhead Bio, Inc. | |
MyMetagenome Co. Ltd. |
















